Skip to main content
Erschienen in: Obesity Surgery 7/2020

10.03.2020 | Original Contributions

Compared with Controls, Bariatric Surgery Prevents Long-Term Mortality in Persons with Obesity Only Above Median Age of Cohorts: a Systematic Review and Meta-Analysis

verfasst von: Antonio E. Pontiroli, Valerio Ceriani, Elena Tagliabue

Erschienen in: Obesity Surgery | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Compared to medical treatment, bariatric surgery reduces long-term mortality in persons with obesity. Some studies indicate that the effect only applies to patients above median age of cohorts, not to younger patients. Our objective was to assess the role of age in the reduction of mortality (global mortality and mortality for specific causes) through bariatric surgery.

Materials and Methods

Data sources: PubMed, Cochrane Library, MEDLINE, and Embase. Study selection: studies reporting mortality in relation to median age of patients. Data extraction and synthesis: pooled random effects of estimates of the risk of mortality in participants undergoing surgery compared with controls, as function of median age.

Results

Mortality was lower in patients undergoing surgery than in controls (OR = 0.29, 95% CI 0.17–0.49). Below median age, the difference between surgery patients and controls was nonsignificant (OR = 0.78, 95% CI 0.57–1.06). Above median age, the difference was significant (OR = 0.23, 95% CI 0.12–0.44). In a subset of 5 studies, deaths due to various causes were less, and external causes-related deaths were more frequent in surgery than in controls. Below median age, deaths due to CVD were less frequent in surgery than in controls. Above median age, total deaths and deaths due to various causes (cardiovascular, diabetes, cancer, and other causes) were less in surgery than in controls. Publication bias was absent.

Conclusion

Compared with controls, bariatric surgery reduces long-term global mortality only above median age, not below median age. Also mortality due to specific causes is mainly reduced in persons above median age.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213–20.CrossRef MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213–20.CrossRef
2.
Zurück zum Zitat Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.CrossRef Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.CrossRef
3.
Zurück zum Zitat Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.CrossRef Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.CrossRef
4.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström CD, et al. Swedish obese subjects study. Swedish obese patients study. Effects of bariatric surgery on mortality in Swedish obese patients. N Engl J Med. 2007;357:741–52.CrossRef Sjöström L, Narbro K, Sjöström CD, et al. Swedish obese subjects study. Swedish obese patients study. Effects of bariatric surgery on mortality in Swedish obese patients. N Engl J Med. 2007;357:741–52.CrossRef
5.
Zurück zum Zitat Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3:496–502.CrossRef Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3:496–502.CrossRef
6.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, et al. Long-term-mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.CrossRef Adams TD, Gress RE, Smith SC, et al. Long-term-mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.CrossRef
7.
Zurück zum Zitat Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis. 2007;3:73–7.CrossRef Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis. 2007;3:73–7.CrossRef
8.
Zurück zum Zitat Peeters A, O'Brien PE, Laurie C, et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007;246:1028–33.CrossRef Peeters A, O'Brien PE, Laurie C, et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007;246:1028–33.CrossRef
9.
Zurück zum Zitat Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253:484–7.CrossRef Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253:484–7.CrossRef
10.
Zurück zum Zitat Cardoso L, Rodrigues D, Gomes L, et al. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19:1223–32.CrossRef Cardoso L, Rodrigues D, Gomes L, et al. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19:1223–32.CrossRef
11.
Zurück zum Zitat Pontiroli AE, Zakaria AS, Mantegazza E, Morabito A, Saibene A, Mozzi E, Micheletto G; LAGB10 working group. Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol 2016; 15: 39. Pontiroli AE, Zakaria AS, Mantegazza E, Morabito A, Saibene A, Mozzi E, Micheletto G; LAGB10 working group. Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol 2016; 15: 39.
12.
Zurück zum Zitat Davidson LE, Adams TD, Kim J, et al. Association of patient age at gastric bypass surgery with long-term all-cause and cause-specific mortality. JAMA Surg. 2016;151:631–7.CrossRef Davidson LE, Adams TD, Kim J, et al. Association of patient age at gastric bypass surgery with long-term all-cause and cause-specific mortality. JAMA Surg. 2016;151:631–7.CrossRef
13.
Zurück zum Zitat Lent MR, Benotti PN, Mirshahi T, et al. All-cause and specific-cause mortality risk after Roux-en-Y gastric bypass in patients with and without diabetes. Diabetes Care. 2017;40:1379–85.CrossRef Lent MR, Benotti PN, Mirshahi T, et al. All-cause and specific-cause mortality risk after Roux-en-Y gastric bypass in patients with and without diabetes. Diabetes Care. 2017;40:1379–85.CrossRef
14.
Zurück zum Zitat Reges O, Greenland P, Dicker D, et al. Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA. 2018;319:279–90.CrossRef Reges O, Greenland P, Dicker D, et al. Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA. 2018;319:279–90.CrossRef
15.
Zurück zum Zitat Ceriani V, Sarro G, Micheletto G, Giovanelli A, Zakaria AS, Fanchini M, Osio C, Nosari I, Morabito A, Pontiroli AE; LAGB10 working group. Long-term mortality in obese subjects undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) versus medical treatment. Int J Obes 2019; 43:1147–1153. Ceriani V, Sarro G, Micheletto G, Giovanelli A, Zakaria AS, Fanchini M, Osio C, Nosari I, Morabito A, Pontiroli AE; LAGB10 working group. Long-term mortality in obese subjects undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) versus medical treatment. Int J Obes 2019; 43:1147–1153.
16.
Zurück zum Zitat Gribsholt SB, Thomsen RW, Svensson E, et al. Overall and cause-specific mortality after Roux-en-Y gastric bypass surgery: a nationwide cohort study. Surg Obes Relat Dis. 2017;13:581–7.CrossRef Gribsholt SB, Thomsen RW, Svensson E, et al. Overall and cause-specific mortality after Roux-en-Y gastric bypass surgery: a nationwide cohort study. Surg Obes Relat Dis. 2017;13:581–7.CrossRef
17.
Zurück zum Zitat Kauppila JH, Tao W, Santoni G, et al. Effects of obesity surgery on overall and disease-specific mortality in a 5-country population-based study. Gastroenterology. 2019;157:119–27.CrossRef Kauppila JH, Tao W, Santoni G, et al. Effects of obesity surgery on overall and disease-specific mortality in a 5-country population-based study. Gastroenterology. 2019;157:119–27.CrossRef
18.
Zurück zum Zitat Pontiroli AE, Zakaria AS, Fanchini M, et al. A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity. Cardiovasc Diabetol. 2018;17:161.CrossRef Pontiroli AE, Zakaria AS, Fanchini M, et al. A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity. Cardiovasc Diabetol. 2018;17:161.CrossRef
19.
Zurück zum Zitat Moussa OM, Erridge S, Chidambaram S, et al. Mortality of the severely obese: a population study. Ann Surg. 2019;269:1087–91.CrossRef Moussa OM, Erridge S, Chidambaram S, et al. Mortality of the severely obese: a population study. Ann Surg. 2019;269:1087–91.CrossRef
21.
Zurück zum Zitat Raaijmakers LC, Pouwels S, Thomassen SE, et al. Quality of life and bariatric surgery: a systematic review of short- and long-term results and comparison with community norms. Eur J Clin Nutr. 2017;71:441–9.CrossRef Raaijmakers LC, Pouwels S, Thomassen SE, et al. Quality of life and bariatric surgery: a systematic review of short- and long-term results and comparison with community norms. Eur J Clin Nutr. 2017;71:441–9.CrossRef
22.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRef
23.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRef Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRef
24.
Zurück zum Zitat Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardio-vascular risk profile. Am J Cardiol. 2011;108:1499–507.CrossRef Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardio-vascular risk profile. Am J Cardiol. 2011;108:1499–507.CrossRef
25.
Zurück zum Zitat Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese patients with type 2 diabetes. Diabetes Care. 2012;35:2613–7.CrossRef Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese patients with type 2 diabetes. Diabetes Care. 2012;35:2613–7.CrossRef
26.
Zurück zum Zitat Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216:545–56.CrossRef Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216:545–56.CrossRef
27.
Zurück zum Zitat Busetto L, De Stefano F, Pigozzo S, et al. Long-term cardiovascular risk and coronary events in morbidly obese patients treated with laparoscopic gastric banding. Surg Obes Relat Dis. 2014;10:112–20.CrossRef Busetto L, De Stefano F, Pigozzo S, et al. Long-term cardiovascular risk and coronary events in morbidly obese patients treated with laparoscopic gastric banding. Surg Obes Relat Dis. 2014;10:112–20.CrossRef
28.
Zurück zum Zitat Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–87.CrossRef Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–87.CrossRef
29.
Zurück zum Zitat Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190.CrossRef Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190.CrossRef
30.
Zurück zum Zitat Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32:567–74.CrossRef Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32:567–74.CrossRef
31.
Zurück zum Zitat Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018;14:882–901.CrossRef Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018;14:882–901.CrossRef
32.
Zurück zum Zitat Campoverde Reyes KJ, Misra M, Lee H, et al. Weight loss surgery utilization in patients aged 14-25 with severe obesity among several healthcare institutions in the United States. Front Pediatr. 2018;6:251.CrossRef Campoverde Reyes KJ, Misra M, Lee H, et al. Weight loss surgery utilization in patients aged 14-25 with severe obesity among several healthcare institutions in the United States. Front Pediatr. 2018;6:251.CrossRef
33.
Zurück zum Zitat Moher DA, Tetzlaff J, Altman DG, PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 2009; 6: e1000097 Moher DA, Tetzlaff J, Altman DG, PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 2009; 6: e1000097
34.
Zurück zum Zitat Kim SY, Park JE, Lee YJ, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66:408–14.CrossRef Kim SY, Park JE, Lee YJ, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66:408–14.CrossRef
35.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–80.CrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–80.CrossRef
36.
Zurück zum Zitat Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991;337:867–72.CrossRef Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991;337:867–72.CrossRef
37.
Zurück zum Zitat Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1–7.CrossRef Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1–7.CrossRef
38.
Zurück zum Zitat Pontiroli AE, Ceriani V, Tagliabue E, et al. Bariatric surgery, compared to medical treatment, reduces morbidity but does not reduce mortality in patients aged < 43 years, especially if diabetes mellitus is present. A post-hoc analysis of two retrospective cohort studies. Acta Diabetol. 2019 Oct 9; https://doi.org/10.1007/s00592-019-01433-3. [Epub ahead of print] Pontiroli AE, Ceriani V, Tagliabue E, et al. Bariatric surgery, compared to medical treatment, reduces morbidity but does not reduce mortality in patients aged < 43 years, especially if diabetes mellitus is present. A post-hoc analysis of two retrospective cohort studies. Acta Diabetol. 2019 Oct 9; https://​doi.​org/​10.​1007/​s00592-019-01433-3. [Epub ahead of print]
39.
Zurück zum Zitat Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab. 2014;16:719–27.CrossRef Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab. 2014;16:719–27.CrossRef
Metadaten
Titel
Compared with Controls, Bariatric Surgery Prevents Long-Term Mortality in Persons with Obesity Only Above Median Age of Cohorts: a Systematic Review and Meta-Analysis
verfasst von
Antonio E. Pontiroli
Valerio Ceriani
Elena Tagliabue
Publikationsdatum
10.03.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 7/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04530-3

Weitere Artikel der Ausgabe 7/2020

Obesity Surgery 7/2020 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.